Predictors and therapeutic effects of mandibular protrusion therapy for obstructive sleep apnea - a prospective observational study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00024832

Enrollment

500

Registered

2021-03-29

Start date

2021-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G47.31

Interventions

Group 1: Patients with a prescription for a oral appliance therapy

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Prescription of treatment with UKPS regardless of the duration of treatment Men and women, ages 18-80 years Signed patient information and consent form

Exclusion criteria

Exclusion criteria: Missing ability to give consent

Design outcomes

Primary

Measure	Time frame
50% reduction in the apnea-hypopnea index measured with polygraphy or polysomnography Measured at the times: 1. Before treatment with UKPS (baseline) 2. 1-3 months after starting UKPS therapy (follow-up, with UKPS)	—

Secondary

Measure	Time frame
Reduction of daytime sleepiness (Epworth Sleepiness Scale) Collected at the following times: 1. Before treatment with UKPS (baseline) 2. 3-6 months after starting UKPS therapy (follow-up, with UKPS)	—

Countries

Germany

Contacts

Public ContactMichael Arzt

Klinik und Poliklinik für Innere Medizin II Universitätsklinikum Regensburg

michael.arzt@ukr.de+49 (0)941 944-7281

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026